← Leaderboards
David Pepin
Massachusetts General Hospital
$2,535,692
Attributed
$2,535,692
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $724.7K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,535,692 · 2
By mechanism
R01$2,535,692 · 2
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Boris Dominik Juelg$12,991,342
- Patricia K Donahoe$22,937,861
- Todd M Allen$28,600,717
- Michael Lanuti$1,167,985
- Christian L. Boutwell$1,108,916
Others in their field
Other Emerging Leaders on “Mullerian-Inhibiting Substance Receptor”
- Malcolm Mauriece Moses · University Of Tx Md Anderson Can Ctr$63,390
Research focus
Mullerian-Inhibiting Substance ReceptorRecombinantsGrowing FollicleMullerian-Inhibiting HormoneOvaryPrimordial FollicleFertilityGranulosa CellHormonesInsightOvarianOvarian ReserveParacrinePreventFeedbackFemale FertilityFibrosisCellsHomeostasisHormonalChemotherapyInnovationContraceptive AgentsReproductive Biology
Grant awards (6)
Evaluation of the effect of exogenous AMH on ovarian function and fertility$724,714
R01 · FY2025 · HD · contact PI
Methods of fertility protection by Mullerian inhibiting substance in the female reproductive tract during chemotherapy$357,829
R01 · FY2024 · HD · contact PI
Methods of fertility protection by Mullerian inhibiting substance in the female reproductive tract during chemotherapy$361,443
R01 · FY2023 · HD · contact PI
Methods of fertility protection by Mullerian inhibiting substance in the female reproductive tract during chemotherapy$361,443
R01 · FY2022 · HD · contact PI
Methods of fertility protection by Mullerian inhibiting substance in the female reproductive tract during chemotherapy$361,443
R01 · FY2021 · HD · contact PI
Methods of fertility protection by Mullerian inhibiting substance in the female reproductive tract during chemotherapy$368,820
R01 · FY2020 · HD · contact PI